UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Date
of Report (Date of earliest event reported)
|
October
22, 2008
|
|||
|
ENCISION
INC.
|
||||
|
(Exact
name of registrant as specified in its charter)
|
||||
|
Colorado
|
0-28604
|
84-1162056
|
||
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
||
|
6797
Winchester Circle, Boulder, Colorado
|
80301
|
|||
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|||
|
Registrant’s
telephone number, including area code
|
(303)
444-2600
|
|||
|
(Former
name or former address, if changed since last report.)
|
||||
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions (see General Instruction A.2. below):
|
||||
|
o Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
||||
|
o Soliciting
material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||||
|
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
||||
|
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
||||
Item
5.02. Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements for Certain Officers.
Effective
October 22, 2008, George A. Stewart resigned as a director of Encision Inc.
(the
“Company”). Mr. Stewart resigned for personal reasons and did not resign
because of a disagreement with the Company’s management or on any matter
relating to its operations, polices or practices.
Effective
October 22, 2008, Ruediger Naumann-Etienne was appointed to serve as a director
of the Company. The Company’s Board of Directors (the “Board”) has not yet
determined the committee or committees of the Board, if any, on which Mr.
Naumann-Etienne will serve.
[Mr.
Naumann-Etienne has been the General Partner of Intertec Healthcare Partners,
a
fund investing in medical companies since 2006. The fund currently owns 10.1%
of
the Company’s shares. Since 1989 he has also been the owner and Managing
Director of Intertec Group, an investment company specializing in the medical
technology field. Intertec Group has successfully implemented growth strategies
for OEC Medical Systems, Laserscope, Quinton Instruments and Cardiac Science.
Since 2006 he has been Chairman of Cardiac Science having previously served
as
the Chairman of a predecessor company, Quinton Instruments, from 2000 to
2005.
He was also CEO of Quinton Instruments from 2000 to 2003. From 1993 until
1996
he was Chairman of OEC Medical Systems and CEO of the same company from 1995
to
1997. Mr. Naumann-Etienne is also a director of Bio-Rad Laboratories and
Varian
Medical Systems.]
There
are
no understandings or arrangements between Mr. Naumann-Etienne and any other
person pursuant to which he was selected as a director.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
ENCISION
INC.
(Registrant)
|
||
| |
|
|
| Date October 24 , 2008 | By: | /s/ Marcia K. McHaffie |
|
Marcia K. McHaffie |
||
|
Controller
Principal
Accounting Officer
|
||